AiXin Life International, Inc. (AIXN)
AiXin Life International, Inc. operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Chengdu, SI, CN. The stock last traded at $0.26, up 0.00% on the session, giving a market capitalisation of $6.5M. On trailing twelve-month figures it carries a trailing P/E of -3.18, a net margin of -137.1%. Its beta of -3.02 implies it has historically moved less than the broad market.
AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. The company operates through four segments: Direct Sales, Pharmacy, Hotel, and Manufacture and Sale. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat’s milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. The company also engages in hotel business. It provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. The company sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. The company is based in Chengdu, China.
AiXin Life International, Inc. is most often compared with the following Healthcare names: